Resistance to antineoplastic therapy: The oncogenic tyrosine kinase-Bcl-xL axis

Cancer Cell

Volumn 5, Issue 1, 2004, Pages 3-4

  Weintraub, Steven J ^a   Manson, Scott R ^a   Deverman, Benjamin E ^b  

^a USA   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; ANTINEOPLASTIC AGENT; ASPARAGINE; ASPARTIC ACID; BCR ABL PROTEIN; BIM PROTEIN; DIMER; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; ETOPOSIDE; IMATINIB; ONCOPROTEIN; PROTEIN BCL XL; PROTEIN KINASE LCK; PROTEIN TYROSINE KINASE; TAMOXIFEN;

AMINO ACID SUBSTITUTION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESISTANCE; DEAMINATION; DIMERIZATION; DNA DAMAGE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; GAMMA RADIATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; LIGAND BINDING; LIVER CELL CARCINOMA; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE; PHILADELPHIA 1 CHROMOSOME; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION; T CELL LYMPHOMA; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR CELL; UPREGULATION;

EID: 1642430931     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00338-6     Document Type: Review

References (13)

1. Amarante-Mendes G.P., McGahon A.J., Nishioka W.K., Afar D.E., Witte O.N., Green D.R. Oncogene. 16:1998;1383-1390.
2. Blume-Jensen P., Hunter T. Nature. 411:2001;355-365.
3. Cheng E.H., Wei M.C., Weiler S., Flavell R.A., Mak T.W., Lindsten T., Korsmeyer S.J. Mol. Cell. 8:2001;705-711.
4. Deverman B.E., Cook B.L., Manson S.R., Niederhoff R.A., Langer E.M., Rosova I., Kulans L.A., Fu X., Weinberg J.S., Heinecke J.W.et al. Cell. 111:2002;51-62.
5. Horita M., Andreu E.J., Benito A., Arbona C., Sanz C., Benet I., Prosper F., Fernandez-Luna J.L. J. Exp. Med. 191:2000;977-984.
6. Karni R., Jove R., Levitzki A. Oncogene. 18:1999;4654-4662.
7. Kumar R., Mandal M., Lipton A., Harvey H., Thompson C.B. Clin. Cancer Res. 2:1996;1215-1219.
8. Oetzel C., Jonuleit T., Gotz A., van der Kuip H., Michels H., Duyster J., Hallek M., Aulitzky W.E. Clin. Cancer Res. 6:2000;1958-1968.
9. Schlessinger J. Cell. 103:2000;211-225.
10. Skorski T. Nat. Rev. Cancer. 2:2002;351-360.
11. Takehara T., Takahashi H. Cancer Res. 63:2003;3054-3057.
12. Zamo A., Chiarle R., Piva R., Howes J., Fan Y., Chilosi M., Levy D.E., Inghirami G. Oncogene. 21:2002;1038-1047.
13. Zhao R., Yang F.T., Alexander D.R. Cancer Cell. 5:2004;. this issue.